Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of endogenous GLP-1 on arterial stiffness and renal haemodynamics following bariatric surgery.

European journal of clinical investigation·2024
Same author

Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study.

Diabetes & metabolism·2021
Same author

Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project.

High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension·2020
Same author

THE role of metabolic syndrome in blood pressure control and pulse wave velocity progression over a 3.5 years in treated hypertensive PATIENTS.

European journal of internal medicine·2020
Same author

Improvement in arterial stiffness after short-term treatment with PCSK9 inhibitors.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2019
Same author

Systemic Inflammation after Third Molar Removal: A Case-Control Study.

Journal of dental research·2017
Same journal

MSH4 and MSH5 variants in premature ovarian insufficiency: A literature review and case study.

Maturitas·2026
Same journal

Advancing paternal age: Effects on sperm quality and offspring health.

Maturitas·2026
Same journal

Prevalence of, and factors associated with, urogenital pelvic floor disorders among women from a refugee-background: A cross-sectional study.

Maturitas·2026
Same journal

Association of menopausal type and hormone therapy with headache in a large Taiwanese cohort.

Maturitas·2026
Same journal

Depressive symptoms and risk of incident hip fracture in older adults: A harmonized multinational cohort study.

Maturitas·2026
Same journal

Depressive symptom trajectories around incident hip fracture in older adults: an event-centered matched analysis from the Health and Retirement Study.

Maturitas·2026
See all related articles

Related Experiment Video

Updated: May 25, 2026

Isolation and Functional Analysis of Arteriolar Endothelium of Mouse Brain Parenchyma
06:40

Isolation and Functional Analysis of Arteriolar Endothelium of Mouse Brain Parenchyma

Published on: March 11, 2022

Endothelial aging and gender.

A Virdis1, S Taddei

  • 1Department of Internal Medicine, University of Pisa, Pisa, Italy. a.virdis@med.unipi.it

Maturitas
|February 8, 2012
PubMed
Summary
This summary is machine-generated.

Endogenous estrogen protects endothelial function against aging in premenopausal women. Further research is needed to understand how androgens like testosterone affect endothelial health and nitric oxide production.

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

Related Experiment Videos

Last Updated: May 25, 2026

Isolation and Functional Analysis of Arteriolar Endothelium of Mouse Brain Parenchyma
06:40

Isolation and Functional Analysis of Arteriolar Endothelium of Mouse Brain Parenchyma

Published on: March 11, 2022

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Vascular Biology

Background:

  • The endothelium is crucial for vascular homeostasis, producing nitric oxide (NO) to prevent atherosclerosis.
  • Aging impairs endothelial function, a significant cardiovascular risk factor.
  • Premenopausal women exhibit protection against age-related endothelial dysfunction, potentially due to estrogen.

Purpose of the Study:

  • To investigate the role of endogenous estrogen in preserving endothelial function during aging.
  • To explore the mechanisms by which estrogen protects the endothelium.
  • To address the unresolved question of androgen's effect on endothelial function.

Main Methods:

  • The study focuses on endothelial function in premenopausal women (normotensive and hypertensive).
  • It examines the influence of aging on endothelial nitric oxide availability.
  • Mechanisms investigated include the l-arginine-NO pathway and reactive oxygen species generation.

Main Results:

  • Premenopausal women are protected from age-related endothelial dysfunction compared to age-matched men.
  • Estrogen preserves nitric oxide availability by activating the l-arginine-NO pathway and inhibiting reactive oxygen species.
  • Age-related endothelial dysfunction is attenuated in premenopausal hypertensive women.

Conclusions:

  • Endogenous estrogen plays a protective role in maintaining endothelial function during aging in premenopausal women.
  • Estrogen's protective effects are mediated by enhancing nitric oxide bioavailability.
  • The impact of androgens, such as testosterone, on endothelial function remains unclear due to limited and conflicting data.